Seadrill (SDRL) (ENER) (PDCO) (GEOI) (HEI) Price Targets Changed

Seadrill Ltd (NASDAQ: SDRL), Energy Conversion Devices Inc (NASDAQ: ENER), Patterson Companies Inc (NASDAQ: PDCO), GeoResources, Inc. (NASDAQ: GEOI) and HEICO (NYSE: HEI) price targets adjusted by analysts.

Seadrill Ltd (SDRL) had its price target lowered by Dahlman Rose from $42.00 to $38.00. They have a “Buy” rating on the company.

Energy Conversion Devices Inc. (ENER) had its price target lowered by Ardour Capital from $1.00 to $0.50. They now have a “Reduce” rating on the company.

Patterson Companies Inc. (PDCO) had its price target lowered by analysts at Goldman Sachs (NYSE:GS) to $29.00. They have a “Neutral” rating on the company.

GeoResources, Inc. (GEOI) had its price target lowered by Rodman & Renshaw from $33.00 to $29.00. They have an “Outperform” rating on the company.

HEICO (HEI) had its price target raised by FBR Capital from $52.00 to $56.00. They have a “Market Perform” rating on the company.

IDEX (IEX) (JOYG) (OVTI) (PAG) (SDRL) (MDCO) Ratings Reiterated

IDEX Corp (NYSE:IEX), Joy Global (NASDAQ:JOYG), OmniVision (NASDAQ:OVTI), Penske Auto (NYSE:PAG), Seadrill Ltd (NYSE:SDRL) and The Medicines Co (NASDAQ:MDCO) had ratings on them reiterated by analysts.

Barrington Research reiterated its rating on IDEX Corp. (IEX). They have an "Outperform" rating on the company, and cut its price target from $55 to $45.

Barclays Capital reiterated its rating on Joy Global (JOYG). They have an "Overweight" rating on the company, and cut its price target from $114 to $112.

Needham reiterated its rating on OmniVision (OVTI). They have a "Strong Buy" rating on the company, and slashed their price target on them from $45 to $30.

Ticonderoga reiterated its rating on Penske Auto (PAG). They have a "Buy" rating on the company, and lowered their price target from $27 to $25.

Dahlman Rose reiterated its rating on Seadrill Ltd (SDRL). They have a "Buy" rating on the company, and lowered their price target from $42 to $38.

Argus reiterated its rating on The Medicines Co. (MDCO). They have a "Buy" rating on the company, and cut their price target on them from $25 to $20.